Sexual dysfunction: male and female issues.
In March 1998, a new sexual revolution began. It was at that time that Viagra, a pill for the treatment of male erectile dysfunction, was introduced. Release of this medication not only allowed scientists to identify the basic physiology of erectile functioning but also for the first time allowed men to reverse the natural aging process of loss of an erection. This, unfortunately, failed to address the other most important part of sexual relations: the female partner. It is not until recently that we have begun to recognize the vast importance of the couple's relationship. This paper reviews the pathophysiology of both male and female sexual dysfunctions and their relationships. It describes the testing process that is involved in the ideology and management of sexual dysfunction. The treatment options reviewed include the use of the older methods for male sexual dysfunction, as well as the new pharmacologic treatments and their potential. The treatment of female sexual dysfunction is also addressed.
Steidle
Christopher P
CP
Indiana University School of Medicine, Fort Wayne, USA.
D000527:Alprostadil / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D015917:Penile Prosthesis; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines; D012307:Risk Factors; D012735:Sexual Dysfunction, Physiological / Q000503:physiopathology* / Q000628:therapy; D000068677:Sildenafil Citrate; D013450:Sulfones; D014665:Vasodilator Agents / Q000627:therapeutic use
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D000527:Alprostadil